Filing Flows › Comparisons › FLGT vs CFOR
Fulgent Genetics vs CapForce: FLGT and CFOR compared
Fulgent Genetics is the larger company: $90.4M of revenue in its latest quarter (Q3 2026) against $50.0M for CapForce (Q2 2026). CapForce is growing faster (12× against +8% a year earlier). CapForce is more profitable, with an operating margin of 88.6% against -24.9%.
Where the money goes: FLGT and CFOR
Fulgent Genetics (FLGT) · Q3 2026
Fulgent Genetics, Q3 2026: revenue $90.4M (+8% year over year), operating margin -24.9%, net loss $13.3M, operating cash flow $109M. The chart follows the revenue to costs, profit and cash.
CapForce (CFOR) · Q2 2026
CapForce, Q2 2026: revenue $50.0M (12× year over year), operating margin 88.6%, net earnings $42.5M, operating cash flow −$618K. The chart follows the revenue to costs, profit and cash.
| Fulgent Genetics (FLGT) | CapForce (CFOR) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q2 2026 |
| Revenue | $90.4M | $50.0M |
| Revenue growth, Y/Y | +8% | 12× |
| Operating margin | -24.9% | 88.6% |
| Net earnings | −$13.3M | $42.5M |
| Net margin | -14.8% | 84.9% |
| Operating cash flow | $109M | −$618K |
| Free cash flow | $107M | — |
Questions
Which is bigger, Fulgent Genetics or CapForce?
Fulgent Genetics is the larger company: $90.4M of revenue in its latest quarter (Q3 2026) against $50.0M for CapForce (Q2 2026).
Is Fulgent Genetics or CapForce growing faster?
CapForce is growing faster (12× against +8% a year earlier).
Which is more profitable, Fulgent Genetics or CapForce?
CapForce is more profitable, with an operating margin of 88.6% against -24.9%.
More: Fulgent Genetics earnings · how Fulgent Genetics makes money · CapForce earnings · how CapForce makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Aug 19, 2026). Fiscal quarters can end on different dates. Not investment advice.